Summary Recently, we have found a high frequency of p53 gene mutations in human functional adrenal tumours. As the tumorigenesis is a multigene defect, we believe that other oncogenes may also be involved in the initiation or progression of adrenal tumours. Using the singlestrand conformational polymorphism (SSCP) method, we chose the ras oncogenes as the target in this screening procedure because their high mutation rates were detected in thyroid tumours. For the ras oncogenes analysed, exon 1 to exon 2 of H-ras and K-ras genes in the tumour tissues of 13 Conn's syndrome, two adrenal Cushing's syndrome, two non-functional adrenal tumours, one adrenocortical hyperplasia and eight phaeochromocytomas and its paired adjacent normal adrenal tissues were amplified and sequenced. No mutations were detected in the H-ras gene. But mutations of the K-ras gene were detected in 46% (6 of 13) of Conn's syndrome; the hot spots were located at codon 15, 16, 18 and 31, which were different from those previously found in other tumours (codon 12, 13 and 61). Northern blot analysis with 1.1 kb K-ras cDNA revealed that K-ras mRNA was more than tenfold over-expressed in four of Conn's syndrome, one case of Cushing's syndrome and one case of adrenocortical hyperplasia. The mutation sites and mutation type were not found in other tissues, which confered that this was highly related to adrenocortical tumours. Yet, the correlation between K-ras oncogene and adrenocortical tumours needs to be clarified by further studies.
Many proto-oncogenes encode proteins that transmit signals that regulate normal cell growth (Cantly et al, 1991) . Specific mutations convert these genes into oncogenes (Mark, 1989) . Although some frequently targeted oncogenes are common to many different tumour cell types, others are uniquely mutated in particular forms of neoplasm (Barbacid, 1987) .
Endocrine neoplasms are the major causes of endocrine disease in human beings. All endocrine organs, such as pituitary gland, thyroid gland, parathyroid gland, adrenal gland, pancreas and gonads, are known to possess the possibility to develop neoplasms. Little is known about genetic changes that confer endocrine neoplasms. In 1989, Landis et al (1989) found that 43% pituitary GH-secreting tumours had G-protein mutations. Mutations of ras oncogenes, PTC oncogenes, G-protein and p53 tumour-suppressor genes had been reported in the human thyroid tumours (Eng et al, 1995) . There were few studies concerning the oncogenes and the tumour-suppressor genes in the tumorigenesis of functional adrenal tumours. In 1990, Lyon et al found that 3 of 11 adrenal tumours had G-protein mutations. In 1989, Lemoine et al had reported that activation of ras oncogenes occurred at a very high frequency (80%) in a small series of human thyroid follicular carcinomas. A variety of human tumours has been studied for ras gene mutations to date (Bos, 1989) . However, little is known about the prevalence or significance of activated ras oncogene in adrenal tumours. Recently, we found a high rate of p53 gene mutation in the functional adrenal tumours K-ras oncogene in human adrenal tumours 1061 . An electrophoretic mobility shift of the bands differs between the tumour (T) and its paired normal tissues (N), representing a different conformer of the fragment and suggesting the presence of mutations in this fragment. No electrophoretic mobility shift over the samples tested suggests normal conformations over these samples. P is the positive control of K-ras codon 12 mutant derived from SW480 human colon adenocarcinoma cell line (Lin et al, 1994; 1996) . As the tumorigenesis is a multigene defect (Knudson, 1989) British Journal of Cancer (1998) 
DNA extraction
Genomic DNA was extracted from adrenal tumours and the paired adjacent normal adrenal gland tissues by proteinase-K (Stratagene, La Jolla, CA, USA) digestion and then phenol-chloroform extraction according to Sambrook's method (Sambrook et al, 1989) .
PCR-SSCP analysis
To search the mutations of the K-ras gene using PCR-SSCP analysis, two sets of primers including codon 12, 13 and 61 were used and are described below: 5'-CTGGTTCGGCCCAATGACG-GAATATAAGCTGGTG-3' (forward) and 5'-CTCGCTCGCC-CACGCCAGGCTCACCTCTAT-3' (reverse) for codon 12 and 13 of H-ras gene, which amplify a 148-bp PCR product of codon 1-7; 5'-CTGGTTCGGCCCACTACCGGAAGCAGGTGGTCA-3' (forward) and 5'-CTCGCTCGCCCACGCATGTACTGGTCCC-GCAT-3' (reverse) for codon 61 of the H-ras gene, which amplify a 127-bp PCR product of codon 38-73; 5'-ATGACTGAA-TATAAACTTGT-3' (forward) and 5'-CTCTATTGTTGGATCA-TATT-3' (reverse) for codon 12 and 13 of the K-ras gene, which amplify a 128-bp PCR product of codon 1-37; 5'-TTCC-TACAGGAAGCAAGTAG-3' (forward) and 5'-CACAAA-GAAAGCCCTCCCCA-3' (reverse) for codon 61 of K-ras gene, which amplify a 11 1-bp PCR product of codon 38-81. The reaction mixture contained 50 pmol of each primer, 2.5 U of Taq DNA polymerase (Boehringer Mannheim), 100 mmol L-1 each of British Journal of Cancer (1998) Cloning and sequencing analysis Amplified DNA was desalted and primers were removed by gel filtration with CL-6B Sepharose spin column (Pharmacia LKB Biotechnology, Sweden) and ethanol precipitation. The purified DNA was inserted into pDIRECT vector (Clontech Laboratories, Palo Alto, CA, USA). This material was the template for dideoxy sequencing using MultiPol DNA Sequencing System (Clontech).
[ox-35S] Deoxy-ATP (New England Nuclear Research Products) was used to label sequencing reactions. Plasmid DNA was prepared from isolated colonies using the alkaline lysis method. Doublestranded plasmid DNA was sequenced using T7 and T3 promotor sequences as sequencing primers. The accuracy of our sequencing data was confirmed by analysis of ten independent clones.
Northern blotting
Twenty micrograms of total RNA was denatured with 6.5% formaldehyde. The gels were blotted onto a nitrocellulose membrane (Schleicher and Schuell, Dassel, Germany). The filters were hybridized with a random primed, 32P-labelled, 0.4 kb StuI-EcoRI fragment of K-ras cDNA (Capon et al, 1983 ). The hybridized filters were then washed in 30 mmol 1-' sodium chloride, 3 mmol 1-1 sodium citrate, and 0.1% sodium dodecyl sulphate (at 65°C) and autoradiographed. The membrane was rehybridized with a 700-bp PstI fragment of f-actin probe to correct for differences in loading. The signals on the autoradiography were scanned with a Molecular Dynamics (Sunnyvale, CA, USA) computing laser densitometer and MD ImageQuant software release version 3.22.
RESULTS
A total of 13 primary aldosteronism, two Cushing's syndrome, one adrenocortical hyperplasia, two non-functional adrenal tumours and eight adrenal medullary phaeochromocytomas were selected for analysis. Age, sex and tumour size of all patients analysed are summarized in Table 1 . There were 12 men and 14 women, with an age range of 27-63 years. Twenty-four of 26 patients with tumours clinically classified as functioning had detectable hormonal abnormalities; two had no detectable hormonal abnormality classified as non-functioning.
Twenty-six adrenal neoplasms were screened for the presence of activated H-ras and K-ras genes. Seven out of 16 functional adrenocortical adenomas showed an apparent electrophoretic mobility shift of the K-ras gene analysed between the tumour and its paired adjacent normal tissue ( Figure 1) ; no electrophoretic mobility shift was found in the eight phaeochromocytomas and two non-functioning adrenal adenomas. An electrophoretic mobility shift between the tumour and its paired normal tissue is characteristic of a mutation. Six out of seven such differences were detected in exon 1 of the K-ras gene containing codon 12 and codon 13 ( Figure 1A ) and one was detected in exon 2 of the K-ras gene containing codon 61 ( Figure 1B) . Furthermore, the results from SSCP analysis demonstrated that the K-ras gene mutant types were monoallelic in all cases that showed a normal band and British Journal of Cancer (1998) 77(7) 15GGC-*AGC Gly-*Ser 18GCC-*GTC Ala-Val 31 GAA-MCAA Glu-*Gln (Figures 3 and 4) . In the six cases, there were two cases (case 12 and 15) that showed a 10-20 times increase in K-ras mRNA overexpression compared with that in the paired remnant adrenal gland. These results are summarized in Table 2 .
DISCUSSION
The activation of ras genes has been implicated in transformation in vitro and tumorigenesis in vivo (Barbacid, 1987; Vogel et al, 1988; Mikako et al, 1992) , but the role of these genes in the sequential events leading to the acquisition of the transformed phenotype is unclear. The ras-encoded proteins in mammalian cells are approximately 21 000 daltons (p21), bind guanine nucleotides and are localized to the inner face of the plasma membrane (Sigal et al, 1986) . Three members of the cellular ras gene family have been identified:
H-ras, K-ras and N-ras (Hall, 1990) . Oncogenic ras proteins differ from their normal homologues by a single amino acid substitution, usually at positions 12, 13 and 61. It has been proposed that the deficiency in GTPase activity of the ras oncogenic protein could result in the derangement of normal regulatory mechanisms that control cell proliferation (Gibbs et al, 1985; Der et al, 1986; Bos, 1989 (Barbacid, 1990) , we chose the H-ras and K-ras genes as the first target analysed. In the present study, no Hras gene mutations were found in the 26 cases with adrenal tumours; we deduced that the H-ras oncogene has little to do with the tumorigenesis of functional adrenal tumours. But in the K-ras oncogene investigation it was confirmed that 6 out of 13 cases with Conn's syndrome had obvious K-ras oncogene mutations, and the mutation rate was high at 46%. The mutation sites were not located on the hot spots on codon 12, 13 and 61 as has been established already, but they were, however, accumulated on codon 15, codon 16, codon 18 and codon 31. The mutation types in those cases were found to be monoallelic. Their mutation sites have not been reported in previous studies of K-ras gene mutation. The results of bidirectional sequencing of ten individual clones confirmed that these sites were mutated in the adrenal tumour specimens we collected. However, Sigal et al (1986) found p21 protein Lysl6 was the decision site of the GTP/GDP-binding site. If Lys-16 is replaced by Asn, the affinity between GTP and GDP will decrease 100 times, without affecting GTP/GDP-binding specificity. , Power et al (1989 designed a mutant p21 protein with Ala instead of Gly-15 for studying the characters of the p21 protein. The results showed that this alteration could also affect the normal functions of the p21 protein. In addition, in Shirouzu et al (1992 , in further studies of the mutation of the p21 protein Glu-31 replaced by Lys, found that this mutation could interfere in the signal transduction activity of the p21 protein by interfering the co-operation of the p21 protein and GAP (GTPase activating protein). Over-expression of K-ras mRNA occurs in approximately 37.5% (6 of 16 cases tested) of functional adrenocortical adenomas and predominantly occurred with the presence of mutations in the K-ras gene. This phenomenon was also found in mouse adrenocortical tumour cells (Schwab et al, 1983; George et al 1984; George et al, 1985) . The phenomenon of over-expression of K-ras mRNA has been investigated by Schwab et al. (1993) in mouse models. They suggested that the overexpression of K-ras mRNA might be caused by K-ras gene amplification. We believe that the overexpression of K-ras mRNA found in our samples of human adrenal tumours may be for the same reason.
